KPIs & Operating Metrics(New)
Animal Health Revenue BreakdownBreakdown Of AssetsEmployee StatisticsGross Margin %Gross ProfitGross Profit AnnualGross Profit Annual %InventoriesLong Lived Assets By RegionNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Operating Expense SegregationOpex As A % Of Total Revenue %Pharmaceuticals Revenue BreakdownPharmaceuticals Revenue Breakdown AnnualPrice Change By Region %Price Change By Region Annual %Price, Volume & Rate Change Total %Property And Equipment SegregationRate Change By Region %Rate Change By Region Annual %Revenue By Business VerticalRevenue By Business Vertical %Revenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By Customer LocationRevenue By Customer Location %Revenue By Customer Location AnnualRevenue By Customer Location Annual %Revenue By RegionRevenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Volume Change By Region %Volume Change By Region Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsR&D In ProcessReceivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Eli Lilly (LLY) Gross Profit (2009 - 2025)

Eli Lilly posted annual Gross Profit of $54.1 billion for FY2025, up 47.79% year-over-year from $36.6 billion in FY2024.

Eli Lilly (LLY) has 17 years of Gross Profit data on file, last reported at $54.1 billion in FY2025.

  • For the quarter ending Q1 2026, Gross Profit rose 54.44% year-over-year to $16.2 billion; the trailing twelve-month figure through Mar 2026 stood at $59.8 billion (up 49.48% YoY), and the FY2025 full-year result was $54.1 billion, up 47.79% from the prior year.
  • Gross Profit for FY2025 stood at $54.1 billion, up from $36.6 billion in the prior year.
  • Across five years, Gross Profit topped out at $54.1 billion in FY2025 and bottomed at $21.0 billion in FY2021.
  • The 5-year median for Gross Profit is $27.0 billion (2023), against an average of $32.1 billion.
  • The widest annual swing landed in 2022, when Gross Profit climbed 4.31%; it then jumped 47.79% in 2025.
  • A 5-year view of Gross Profit shows it stood at $21.0 billion in 2021, then gained by 4.31% to $21.9 billion in 2022, then advanced by 23.41% to $27.0 billion in 2023, then surged by 35.44% to $36.6 billion in 2024, then soared by 47.79% to $54.1 billion in 2025.
  • The last three Gross Profit figures came in at $54.1 billion (FY2025), $36.6 billion (FY2024), and $27.0 billion (FY2023), per Business Quant data.